Who owns MOLECULIN BIOTECH INC COM?
- CUSIP Number: 60855d309
Tip: Access positions for across all investors
Analyze quarterly positions in Moleculin Biotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Moleculin Biotech stock
Who bought or sold MOLECULIN BIOTECH INC COM this quarter?
There are no current stakeholders of Moleculin Biotech.
This is normal when the security:
- Has been acquired or taken private
- Has merged with another entity
- Has changed its name and has a new CUSIP (and/or symbol)
- Has been delisted and the ticker has changed
Please use Search to find the security you were looking for.
Who sold out of Moleculin Biotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Group | Sep 2025 | 240k | $127k |
| Geode Capital Management | Sep 2025 | 208k | $110k |
| Hrt Financial | Sep 2025 | 115k | $61k |
| LPL Financial | Sep 2025 | 58k | $31k |
| Ieq Capital | Sep 2025 | 36k | $19k |
| Wealth Dimensions Group | Sep 2025 | 20k | $11k |
| Rockefeller Capital Management | Sep 2025 | 15k | $7.7k |
| Cambridge Investment Research Advisors | Sep 2025 | 13k | $7.0k |
| Goldman Sachs Group | Sep 2025 | 13k | $6.8k |
| BlackRock | Sep 2025 | 12k | $6.6k |
| Branch Banking & Trust Company | Sep 2025 | 11k | $5.6k |
| Ethos Financial Group | Sep 2025 | 10k | $5.3k |
| Moors & Cabot | Sep 2025 | 10k | $5.3k |
| Tower Research Capital | Sep 2025 | 8.4k | $4.4k |
| UBS Group | Sep 2025 | 4.0k | $2.1k |
| Newbridge Financial Services Group | Sep 2025 | 2.9k | $1.5k |
| SBI Securities | Sep 2025 | 746.00 | $395.007000 |
| Bogart Wealth | Sep 2025 | 300.00 | $159.000000 |
| Advisor Group Holdings | Sep 2025 | 43.00 | $19.999300 |
| CVA Family Office | Sep 2025 | 34.00 | $17.999600 |
| North Star Investment Management | Sep 2025 | 17.00 | $8.999800 |
| Nbc Securities | Sep 2025 | 14.00 | $7.000000 |